MELBOURNE, Australia, July 21, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (GENE) (NASDAQ: GENE, “Company”) a global leader in genomics-based tests in health, wellness and serious disease, ...
MELBOURNE, Australia, July 16, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness, and ...
MELBOURNE, Australia, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven ...
Genetic Technologies (AU:GTG) has released an update. Genetic Technologies Limited has extended the closing date for its Entitlement Offer and prolonged the voluntary suspension of its securities ...
Genetic Technologies (AU:GTG) has released an update. Genetic Technologies Limited has announced an extension for its Entitlement Offer Prospectus until December 2, 2024, providing investors more time ...
MELBOURNE, Australia, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results